논문KCI 등재
Can Patients with Clarithromycin-Resistant Helicobacter pylori Infection Be Treated with a 7-Day Bismuth-Based Quadruple Therapy?
2
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (10)
- Malfertheiner P, "Management of Helicobacter pylori infection-the Maastricht V", Florence Consensus Report, 2017, pp.66, 6~30
- Graham DY, "Helicobacter pylori treatment in the era of increasing antibiotic resistance", Gut, 59, pp.1143~1153 (2010)
- Jung HK, "Evidence-based guidelines for the treatment of Helicobacter pylori infection in Korea 2020", Gut Liver, 15, pp.168~195 (2021)
- Chang YW, "Cost-effectiveness of empirical bismuth-based quadruple therapy and tailored therapy after clarithromycin resistance tests for Helicobacter pylori eradication", Dig Dis Sci, 67, pp.1222~1230 (2022)
- Duan M, "Optimal duration of bismuth-containing quadruple therapy for helicobacter pylori eradication : a systematic review and meta-analysis", Helicobacter, 29, pp.e13144~ (2024)
- Moon SG, "Seven days of bismuth-based quadruple therapy is as effective for the first-line treatment of clarithromycin-resistant confirmed helicobacter pylori infection as 14 days of bismuthbased quadruple therapy", J Clin Med, 11, pp.4440~ (2022)
- Na SY, "Effective eradication regimen and duration according to the clarithromycin susceptibility of Helicobacter pylori determined using dual priming oligonucleotide-based multiplex polymerase chain reaction", Gut Liver, 17, pp.722~730 (2023)
- Fischbach L, "Meta-analysis : the effect of antibiotic resistance status on the efficacy of triple and quadruple firstline therapies for Helicobacter pylori", Aliment Pharmacol Ther, 26, pp.343~357 (2007)
- Lim CH, "Bismuth-based quadruple therapy as firstline treatment for clarithromycin-resistant Helicobacter pylori infection : a prospective randomized comparison of 7-and 14-day treatment regimens", Gut Liver, 18, pp.970~976 (2024)
- Ding YM, "The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day : a systematic review and meta-analysis", Clin Exp Med, 23, pp.1033~1043 (2023)
관련 논문AI추천
Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens오정환, 임철현거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제6호Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-EfficiencyKim Gwang Ha, Lee Moon Won거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제6호Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?최현호거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제5호Bismuth-Based Quadruple Therapy versus Metronidazole- Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial양영주, Baik Gwang Ho, Bang Chang Seok, Jang Hyun Joo, Kae Sea Hyub, Kim Hak Yang, Kim Jinseob, Lee Sang Pyo, Lim Hyun, Seo Seung In, Shin Woon Geon거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제5호Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection김나영, 박영수, 송인성, 신철민, 이동호, 이승태, 임지현, 조현진거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제4호Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication RegimensKountouras Jannis거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제4호
이 간행물의 다른 논문 (16건)
Thickened Gastric Wall: Simplifying the DiagnosisLee Jong Yeul, 김준성pp. 929-930Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic HorizonsHou Bing, Duan Meili, Liu Xin, Chen Yu, Gao Yuan, Gao Yunyipp. 934-948Cellular Plasticity in Gut and Liver RegenerationKim Minwook, Kim You Sun, Park Yoojeong, Ko Sungjinpp. 949-960Differential Diagnosis of Thickened Gastric Wall between Hypertrophic Gastritis and Borrmann Type 4 Advanced Gastric CancerLee Gin Hyug, Seo Jun-young, Kim Hwa Jung, Jung Hwoon-Yong, Ahn Ji Yong, Choi Kee Don, Na Hee Kyong, Jung Kee Wook, Lee Jeong Hoon, Kim Do Hoon, Song Ho Junepp. 961-969Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens오정환, 임철현pp. 970-976
